HA logo

WFH Humanitarian Aid Program factor makes difference in Venezuela

In 2020, a 21-year-old man with severe hemophilia B from Cojedes, Venezuela, was hospitalized with hip pain and significantly reduced mobility in his leg. Fortunately, he was given factor which was donated by the WFH Humanitarian Aid Program—and he was able to make a full recovery and avoid permanent joint damage.

Also available in: Français Español

In 2020, a 21-year-old man with severe hemophilia B from Cojedes, Venezuela, was hospitalized with hip pain and significantly reduced mobility in his leg. Fortunately, he was given factor which was donated by the WFH Humanitarian Aid Program—and he was able to make a full recovery and avoid permanent joint damage.

The patient had been injured in a car accident ten days before, and his condition had worsened to the point where, when he visited the hospital, he had limited mobility in his leg. An ultrasound indicated that he had a hematoma of a pelvic muscle. An initial dose of 3,000 IUs of factor was given, followed by a therapeutic dose of 1,000 IUs every 24 hours for three days. The WFH Humanitarian Aid Program donated factor immediately improved his condition, and he was soon discharged from the hospital. He is now receiving physiotherapy, and is expected to make a full recovery. He will also retain full mobility in his leg, which means that—unlike many people in developing countries—the accident he was involved in will not result in a permanent reduction to his quality of life.

In 2020, the WFH Humanitarian Aid Program donated nearly 7 million IUs of factor to Venezuela. Since 2015, over 95 million IUs have been given to the South American country, allowing patients with a bleeding disorder to enjoy a better quality of life. To find out more about the WFH Humanitarian Aid Program, please click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and our Contributors, CSL Behring and Takeda. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.